When was Apriori Bio founded?

Apriori Bio was founded in 2020 and raised its 1st funding round 4 years after it was founded.

Where is Apriori Bio located?

Apriori Bio is headquartered in Belmont, United States.

How many employees does Apriori Bio have?

As of May 31, 2026, the latest employee count at Apriori Bio is 22.

Is Apriori Bio a funded company?

Apriori Bio is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jul 08, 2024.

When was the latest funding round of Apriori Bio?

Apriori Bio's latest funding was a $***** Seed round on Jul 08, 2024, with participation from 1 investor.

Where does Apriori Bio rank among its competitors?

Apriori Bio ranks 1st amongst 4 active competitors, of which 2 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was Apriori Bio, which secured $1.1M in Jul, 2024.

Who are the top competitors of Apriori Bio?

Apriori Bio's top competitors include Inceptive, OncoImmunity and AiBIOLOGICS. Among them, Apriori Bio secured the most recent funding round in July, 2024.

Apriori Bio - 2026 Company Profile, Funding & Competitors

Apriori Bio is a seed company based in Belmont (United States), founded in 2020. It operates as an AI-based infection control and vaccine prediction tool for healthcare. Apriori Bio has raised $1.1M in funding from CEPI. The company has 4 active competitors, including 2 funded and 1 that has exited. Its top competitors are Inceptive, OncoImmunity and AiBIOLOGICS.

Company Details

AI-based infection control and vaccine prediction tool for healthcare. The company has developed a biological intecation-based product that uses AI technology for the detection of viral components. The technology has the ability to identify virus variants for vaccine production and infection control.

Website: aprioribio.com
Social
Email ID: *****@aprioribio.com
Part Of

Key Metrics

Founded Year

2020

Location

Belmont, United States

Stage

Seed

Total Funding

$1.1M in 1 round

Latest Funding Round

Seed, Jul 08, 2024, $*****

Investors

CEPI & 1 more

Ranked

1^st among 4 active competitors

Employee Count

22 as on May 31, 2026

Similar Companies

Inceptive & 2 more

View Apriori Bio's full profile

Apriori Bio is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
APRIORI BIO, INC. CIN: 853314049 , United States, Active	Dec 31, 1999	-	29 (As on Dec 31, 2024)	-

Apriori Bio has raised a total funding of $1.1M over 1 round. Its latest funding round was a Seed round on Jul 08, 2024 for $*****. 1 investor participated in its latest round. Apriori Bio has 2 institutional investors.

Here is the list of recent funding rounds of Apriori Bio:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 08, 2024	8211006	Seed	5823479	8603979	3681025	3079864

Access funding benchmarks and valuations. Sign up today!

View details of Apriori Bio's funding rounds and investors

Apriori Bio's employee count trend

Apriori Bio has 22 employees as of May 26. Here is Apriori Bio's employee count trend over the years:

Uncover Apriori Bio's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Apriori Bio include Inceptive, OncoImmunity and AiBIOLOGICS. Here is the list of Top 10 competitors of Apriori Bio, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Apriori Bio 2020, Belmont (United States), Seed	AI-based infection control and vaccine prediction tool for healthcare	$1.1M	Flagship Pioneering, CEPI	45/100
2nd	Inceptive 2021, Palo Alto (United States), Series A	AI-based RNA molecular modeling tool for the vaccine	$120M	Nvidia, Andreessen Horowitz & 3 others	45/100
3rd	OncoImmunity 2014, Oslo (Norway), Acquired	Developer of machine-learning based software for personalized cancer immunotherapy	$7.37M	Radforsk, StartupLab & 2 others	45/100
4th	AiBIOLOGICS 2019, Dublin (Ireland), Unfunded	Provider of AI-based vaccine discovery solutions for drug development	-	-	23/100